Then, the results of ORO staining, TG assay and the levels of Pparα and Srebp1c showed that Rev-erbα shRNA improved lipid metabolism disorder and reduced lipid deposition (Fig. 4B, E). The gene discussed is SREBF1; the disease is Disorder of lipid metabolism.